U.S. 3d Bioprinting Market Size & Outlook, 2023-2030
U.S. 3d bioprinting market, 2018-2030 (US$M)
Related Markets
U.S. 3d bioprinting market highlights
- The U.S. 3d bioprinting market generated a revenue of USD 479.1 million in 2023 and is expected to reach USD 895.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 9.3% from 2024 to 2030.
- In terms of segment, medical was the largest revenue generating application in 2023.
- Dental is the most lucrative application segment registering the fastest growth during the forecast period.
3d bioprinting market data book summary
| Market revenue in 2023 | USD 479.1 million |
| Market revenue in 2030 | USD 895.4 million |
| Growth rate | 9.3% (CAGR from 2023 to 2030) |
| Largest segment | Medical |
| Fastest growing segment | Dental |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dental, Medical, Biosensors, Consumer/Personal Product Testing, Bioinks, Food and Animal Product |
| Key market players worldwide | EnvisionTEC, Organovo Holdings Inc, 3D Systems Corp, Inventia Life, Poietis, Vivax Bio, Cyfuse Biomedical, Cellink, Regemat 3D |
Other key industry trends
- In terms of revenue, U.S. accounted for 20.6% of the global 3d bioprinting market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. 3d bioprinting market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 436.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
3D Bioprinting Market Scope
3D Bioprinting Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. 3d bioprinting market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d bioprinting market will help companies and investors design strategic landscapes.
Medical was the largest segment with a revenue share of 38.51% in 2023. Horizon Databook has segmented the U.S. 3d bioprinting market based on dental, medical, biosensors, consumer/personal product testing, bioinks, food and animal product covering the revenue growth of each sub-segment from 2018 to 2030.
Major factors contributing to market growth include the increasing geriatric population, strong government support for quality healthcare, supportive reimbursement policies in the U.S., and several leading players in the country. For instance, 3D Systems, a U.S. Additive Manufacturing (AM) company, is currently one of the world’s major providers of 3D printing for healthcare providers.
For instance, in 2021, Inventia launched its operations in the U.S. to expand operations in the country, where the market for biomedical research and drug discovery is now projected to be worth more than USD 40 billion. In addition, universities and research institutions are also adopting this technology and training professionals.
For instance, Carnegie Mellon University is providing new specialized graduate certificate programs. These online programs are designed to give engineers and data-driven professionals additional training in Artificial Intelligence (AI), 3D bioprinting, and machine learning.
Reasons to subscribe to U.S. 3d bioprinting market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. 3d bioprinting market databook
-
Our clientele includes a mix of 3d bioprinting market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. 3d bioprinting market , including forecasts for subscribers. This country databook contains high-level insights into U.S. 3d bioprinting market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. 3d bioprinting market size, by application, 2018-2030 (US$M)
U.S. 3D Bioprinting Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
